Medscape1d
NICE Approves Fenfluramine for Lennox-Gastaut Syndrome
The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.
openaccessgovernment2d
New NHS treatment offers hope for children with Lennox–Gastaut syndrome
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
MONTCO.Today on MSN2d
Plymouth Meeting’s Harmony Biosciences Pivots After FDA Rejects Wakix for Sleep Disorder
Plymouth Meeting’s Harmony Biosciences’ stock fell 10% on Wednesday after the FDA rejected the expansion of its insomnia drug ...
learningdisabilitytoday.co.uk3d
New epilepsy treatment for Lennox–Gastaut syndrome
NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...
National Health Executive3d
Groundbreaking new child epilepsy treatment
Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...
National Institute for Health and Care Excellence3d
New life-changing treatment option recommended to help control seizures for type of rare epilepsy
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
Hope for children with severe form of epilepsy as NHS rolls out new drug
Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...
NHS England3d
NHS rolls out life-changing treatment offering ‘new hope’ for hundreds of children with severe epilepsy
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their ...